Piper Sandler Maintains Biomarin Pharmaceutical(BMRN.US) With Buy Rating, Maintains Target Price $122

Futu NewsOct 23 20:31 · Ratings

Here's Why BioMarin Pharmaceutical (BMRN) Is a Strong Growth Stock

Zacks Oct 17 20:50

Possible Bearish Signals With BioMarin Pharmaceutical Insiders Disposing Stock

Simply Wall StOct 16 23:22

BioMarin to Host Third Quarter 2024 Financial Results Conference Call and Webcast on Tuesday, October 29, 2024, at 4:30pm ET

PRNewswireOct 16 20:30

How Is The Market Feeling About Biomarin Pharmaceutical?

BenzingaOct 16 01:30

Stifel Maintains Biomarin Pharmaceutical(BMRN.US) With Buy Rating, Maintains Target Price $87

Futu NewsOct 11 21:33 · Ratings